Literature DB >> 21982025

Peripartum hysterectomy in the United States: nationwide 14 year experience.

Brian T Bateman1, Jill M Mhyre, William M Callaghan, Elena V Kuklina.   

Abstract

OBJECTIVE: The objective of the study was to examine the trends in the rate of peripartum hysterectomy and the contribution of changes in maternal characteristics to these trends. STUDY
DESIGN: This was a cross-sectional study of peripartum hysterectomy identified from hospitalizations for delivery recorded in the 1994-2007 Nationwide Inpatient Sample.
RESULTS: The overall rate of peripartum hysterectomy increased by 15% during the study period. The rate of hysterectomy for abnormal placentation increased by 1.2-fold; adjustment for previous cesarean delivery explained nearly all of this increase. The rate of hysterectomy for uterine atony following repeat cesarean delivery increased nearly 4-fold, following primary cesarean delivery approximately 2.5-fold, and following vaginal delivery about 1.5-fold. This fast growing trend in peripartum hysterectomy secondary to uterine atony was also largely explained by increasing rates of primary and repeat cesareans.
CONCLUSION: Rates of peripartum hysterectomy increased substantially in the United States from 1994 to 2007; much of this increase was due to rising rates of cesarean delivery.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21982025     DOI: 10.1016/j.ajog.2011.07.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  28 in total

1.  Reply: To PMID 22405526.

Authors:  Brian T Bateman; William M Callaghan; Elena V Kuklina
Journal:  Am J Obstet Gynecol       Date:  2012-03-10       Impact factor: 8.661

2.  Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.

Authors:  B T Bateman; S Hernandez-Diaz; K F Huybrechts; K Palmsten; H Mogun; J L Ecker; E W Seely; M A Fischer
Journal:  BJOG       Date:  2013-09-11       Impact factor: 6.531

3.  Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007.

Authors:  Jill M Mhyre; Alexander Shilkrut; Elena V Kuklina; William M Callaghan; Andreea A Creanga; Sari Kaminsky; Brian T Bateman
Journal:  Obstet Gynecol       Date:  2013-12       Impact factor: 7.661

4.  Emergency Obstetric Hysterectomy: A Retrospective Study from a Teaching Hospital in North India over Eight Years.

Authors:  Jaya Chawla; D Arora; Mohini Paul; Sangita N Ajmani
Journal:  Oman Med J       Date:  2015-05

Review 5.  Transfusion and coagulation management in major obstetric hemorrhage.

Authors:  Alexander J Butwick; Lawrence T Goodnough
Journal:  Curr Opin Anaesthesiol       Date:  2015-06       Impact factor: 2.706

6.  Usefulness of vessel-sealing devices for peripartum hysterectomy: a retrospective cohort study.

Authors:  Diego Rossetti; Salvatore Giovanni Vitale; Giorgio Bogani; Agnese Maria Chiara Rapisarda; Ferdinando Antonio Gulino; Luigi Frigerio
Journal:  Updates Surg       Date:  2015-03-27

7.  Second-line uterotonics and the risk of hemorrhage-related morbidity.

Authors:  Alexander J Butwick; Brendan Carvalho; Yair J Blumenfeld; Yasser Y El-Sayed; Lorene M Nelson; Brian T Bateman
Journal:  Am J Obstet Gynecol       Date:  2015-01-09       Impact factor: 8.661

8.  Population-based risk for peripartum hysterectomy during low- and moderate-risk delivery hospitalizations.

Authors:  Alexander M Friedman; Jason D Wright; Cande V Ananth; Zainab Siddiq; Mary E D'Alton; Brian T Bateman
Journal:  Am J Obstet Gynecol       Date:  2016-06-24       Impact factor: 8.661

9.  Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume.

Authors:  Shravya Govindappagari; Jason D Wright; Cande V Ananth; Yongmei Huang; Mary E DʼAlton; Alexander M Friedman
Journal:  Obstet Gynecol       Date:  2016-12       Impact factor: 7.661

10.  Emergency peripartum hysterectomy: our experience.

Authors:  A E Tahaoglu; D Balsak; C Togrul; M Obut; O Tosun; Y Cavus; H Bademkiran; S Budak
Journal:  Ir J Med Sci       Date:  2015-11-20       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.